Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JPetro claims
When they conference call entered the Q&A session, both stock analysts and individual investors calls were taken. The host would ask your name and the company you represent. Every private investor told the host they were a private investor, and were described that way when introduced on the call to ask their question to Gerald and other company executives on the call.
JPetro didn't identify himself as a private investor. Not once, but twice on separate calls. One could understand this error happening once, especially to an investor who was participating in their first conference call... but when the second conference call came about, one would expect the error from the first call to be corrected. It wasn't corrected. JPetro provided the company JWP Inc. again when queried by the host.
The first time could have been a mistake. The second time was clearly intentional. Any claim this was an error on the host's part is bullshit. Being portrayed on the call as an analyst was a big pump to the ego.
And he wonders why no one would take seriously his request to buy Amarantus shares after the Come to Jesus talk with the CEO.
I will post links to the calls here for all to listen when I return home. I'm traveling at the moment and don't have access to the audio files. He wants proof? I'll provide the proof. Since he is in the position of moderator again, I don't expect the links to remain as he will delete them to save face as he's done in the past. That proof is posted on reddit.
Bullshit!! If the misidentification occurred a single time, one might accept your explanation. But it didn't occur once. It happened on TWO different Amarantus calls, and in the second instance, once again you failed to correct the error made. How do you explain that? You weren't aware? Really? You pick apart every word of press releases, filings, Geralds quotes, etc., but you miss being misidentified as a stock analyst on two consecutive investor calls?
Not likely. The more likely reason is you CHOSE not to correct them because you enjoyed being presented as an analyst. It pumped your ego and sense of self importance.
I was provided the audio files by AMBS investors. I've shared them with Redspeed so he's also aware of your BS. You are clearly presented as an analyst from JWP Inc. on both calls.
Todos Medical website back up on b2i digital
https://b2idigital.com/todos-medical
Looks like it's basically a way to contact Todos management. I made an inquiry to Todos on the website. I'll post if I get a response. Site provides a lot of the info available on the previous site, but Gerald is still listed as CEO, so it's not current.
The mytollovid.com website is still active.
Dickwad, I only posted the update from GC. Some readers without X accounts were asking for any update since no news released since the insolvency announcement. This IS the Todos board. One would assume a moderator would expect relevant info to be posted here. But then again, most moderators on these boards aren't afflicted with Gerald Derangement Syndrome and Covid-induced brain fog and memory issues. You have no business being a moderator here. Your bias is blatant.
I suggest you go pump your neighbor's cat for exercise after your next pizza arrives. Still haven't figured out who sent those, have you? I though the Domino's crack IT team was all over it.
Might want to go light on the pizza these days. Last time I saw you the man boobs were getting rather large. A bra might in your future.
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
https://ir.novavax.com/press-releases/2024-02-20-Novavax-to-Host-Conference-Call-to-Discuss-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Operational-Highlights-on-February-28,-2024
Hugh was the guy who provided the balls, from the analyst's favorite movie. One could interpret this as Hugh about to introduce these investors to his potential and their catastrophic losses. The analyst often expresses himself in really strange ways, but has posted many pics on the Todos board from this movie, so we can be assured this image will feel as natural as rain.
Wow, Frank/Mom's house is only 85 miles from the JWP Inc. stock analyst's house. I wonder if they've met in person. Perhaps they shared some investment strategies over a few beers and slices of delicious brick oven Brooklyn-style pizza. Or perhaps a Come To Jesus phone call took place. I hear those are all the rage these days, but only if you are successful convincing naive investors to buy more shares while you are selling yours. 🤫
I wonder if the JWP analyst has started a collection of Frank photos to share with the board.
I concede an email reply from the CEO answering an investor question about company updates doesn't quite hold a candle to a COME TO JESUS phone call with the CEO, but most investors don't have their head up Gerald's arse they way you did at AMBS. I suppose that's the reason for the extensive pic collection of the CEO that's maintained on your PC. Are there framed pics on the walls? Are there pics of CEO and shareholder/analyst arm-in-arm at a AMBS shareholders meeting? I suppose that would really inflate one's ego, eh? Even more so than that special COME TO JESUS call with the CEO. How unfortunate all the other investors failed to believe the crap you tried to lay on them after that call. Everyone suspected you were advising them to BUY to drive up the share price while you unloaded your shares.
Have you recovered those catastrophic AMBS losses yet? Certainly not with IBIO or MONI or any other stocks on the boards posted on. Those all SUCK and only added to the six-figure losses. Please let the board know of any other investments you recommend where those here with losses may try to recover their money with some actual gains.
MOO Silence on that question
Why are you replying to my posts? Didn't you have me on IGNORE? What happened? Gerald Derangement Syndrome kicking in again? Can't control yourself, right? That GDS is a nasty thing, sadly with no cure until death.
So funny how none of the Todos criteria you post applies to your MONI investment. Anyone who follows that board knows exactly what I'm talking about. Todos had millions in quarterly revenue at one point. MONI has yet to generate a dime of revenue. If Todos failed, it's because it failed as an operating company, not as a scam where not a single transaction has completed. MONI CEO reported gold mines acquisitions, air service acquisitions, BitGift revenue production and subsequent sale, etc. Where's the claims of SCAM from investors like yourself? Nonexistent. Surprise, Surprise!!
And where was the outrage when your IBIO CEO, who was getting a ridiculous annual salary/bonus, exited the company with an even more ridiculous golden parachute package, after having performed multiple reverse splits on the stock, all while the revenue dried up? All you ever posted was BUY BUY BUY!!! Why no crying about the criminal CEO there, posting hundreds of photos of the CEO, etc? BUY BUY BUY!!! Who's the pumper on that board?
Todos was a risky investment that had great potential. You lost no money here, but will hang around for another decade complaining about over investing and catastrophic losses in AMBS and your love/hate relationship with the CEO. Those of us you claim were company shills lost real investment money here, but you haven't seen even one of us crying about it on any board. I look in my mirror and see a man who takes responsibility and accountability for his decisions, whatever they may be. What do you see in your mirror? And how long do you intend to continue to cry about your losses? Ever think of growing a backbone and man up?
And I thought you had me on IGNORE, yet you read my GC post.
MOO extreme hypocrisy
MOO stiffing the Dominos delivery guy
I thought you had me on ignore. GDS won't allow that. It inhibits one's ability to control themselves. But please do tell us... inquiring minds really want to know... was it BACK DOOR delivery? LMAO
I know you lean that way given the number of times you've mentioned Gerald's c**k in numerous PMs. Did the pizza delivery get your juices flowing?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173819808
And Joe Biden believes he is mentally competent. Everyone can see he isn't except him.
Wow, with evidence like that, IHUB will have no choice other than boot me off their platform. LMAO
With such quality investigative skills, it's becoming very clear why there are ZERO winners in your investment portfolio.
I could reveal who I am, but since it was unlikely you knew Warp's identity, that wouldn't prove anything. Not that such details matter in a person's delusional state. The impact of multiple Covid infections is becoming clearer with each new post.
You've made claims that I am posing as multiple posters. If that's the case, provide evidence to ADVFN and they will close my account, since multiple accounts are not allowed per their Terms of Use.
From the evidence you've collected from your many claims, it should be easy for you to prove. Let's see how ADVFN evaluates the "evidence" you present. Be sure to include the fact you've had Covid multiple times, and of course, your age. Those factors will be considered.
Who will I be next week?
Yawn. 🙄
Prove it. You can't. Nothing but Covid-induced brain fodder.
Sometimes a person needs separate email accounts so they can receive their private electronic issues of PlayGirl away from the prying eyes of the wife and other family members. Hence the fascination with GC's private parts so often mentioned in PMs to board posters. A girl can dream, can't she? LOL
This is similar to the attitude our government bureaucrats often have... multiple email accounts okay for ME, but not for THEE. Didn't the AMBS/TOMDF stock analyst work for a government agency at one point? All the pieces falling into place now... explains a lot.
Really? Shareholders blaming me for their losses in Todos? Must be relatives of yours. Most people take responsibility for their investment decisions, and don't base their decisions on the fact that someone they don't even know is buying shares. But hey, if that's how your family operates, then no wonder financial insolvency exists there.
I'm sorry some here are unable to read and comprehend. Let me explain it like I would to a small child.
Email accounts can be used in the following ways.
1. Your normal, full-time email account you use to correspond with family, friends, and other contacts used in everyday life, such as doctors, pharmacies, investments, etc.
2. Email accounts that are temporary, and are used to provide to certain websites where you're not sure you want to have an ongoing relationship, such as trial memberships, etc. where you need an actual email address to receive confirmation codes or emailed links to obtain the information or service you are requesting, and where you don't want to reveal your normal email address. This greatly helps to eliminate spam to your regular email address, and when spam to the temporary address gets too much, you can delete it and create a new temporary address and start over. You can always change to your normal email address with the service should you choose to continue as a member or customer.
3. Fictitious email address that are not actually created, but are made up on the fly when asked to enter an email address, so you can get past the initial website screens. An example where I used this is to obtain access to the investor conference calls with Sequire where I didn't want to share my normal or temporary email address. This works when the only check is that the email address provided is in a valid format. No check is done that an actual email account exists to allow you to access the content desired. They probably will send an email to the address, and it will be rejected because you made it up. However, even a made-up email address may exist.
I explained this to my neighbor's 8-year-old and she understood it. But then again, she hasn't had Covid multiple times and probably doesn't have loss of mental acuity and brain fog like some posters here. And fortunately she has never been afflicted with GDS, for which there is no cure.
Dipshit, once again I have no fake IP addresses, multiple aliases, or burner phones. I do use a VPN for the purpose of hiding my true IP address, but I have used this for years and have no plans to change. It has nothing to do with posting on message boards. As already explained, my recommendation to use a different email address is based on eliminating spam. Your real email address should only be used in instances where you intend to conduct ongoing business or contact with a website or company. I have often made up an email address on the fly, not knowing if it was a real one or not, to gain access to some websites such as conference calls. It gets you past the initial screening where they are harvesting contact info so they can sell your info to other companies, and that's when the spam emails begin. This is a tactic many use. The internet can be a risky place, and only the ignorant or less sophisticated person reveals their real info in every site visited.
I bet you give your SSN to the doctor's office receptionist when they ask of it, instead of asking why they would need it, or freely provide your email and phone number to merchants who request it at checkout. This info benefits them, not you. No wonder you suffered financial ruin and insolvency, as you've posted on this very board. I documented those posts on Reddit after you denied them here and removed my posts responding to your challenge to prove it. Providing your real name and info on public message boards is a foolish act, especially with how you treat people on those boards. It's amazing some nutcase hasn't visited you and cleaned your clock by now. You might want to rethink your approach.
Yes, absolutely report those named to the SEC. I have lots of experience dealing with regulatory personnel, so I welcome their investigation into the facts here. It's not shareholders who actually purchased shares and kept abreast of and posted Todos info that should be worried. Our claims are documented here and in news releases and in our broker statements.
I believe the SEC would be very interested to follow the posting history of someone we will point out has a very spotty records of pumping certain stocks, including Amarantus, while they were flipping shares. We have the two conference call transcripts and audio recordings where this individual let himself be presented both times as a stock analyst and did nothing to correct the error.
And then there's the Come to Jesus call with the Amarantus CEO. I wonder if GC recorded that. I'm pretty sure he was recording the call I had with him as a Todos shareholder. Those recordings would be available to SEC if requested. And I'm sure if they contacted some of the Amarantus shareholders who were contacted via email and phone after that call with Gerald, they would testify this individual was trying to convince them to buy as many AMBS shares as they could. I wonder what the person's brokerage statements looked like at that time, as it is commonly believed he was unloading his shares. The reason no one followed through on his request is because by that point everyone knew he couldn't be trusted.
By all means, contact the SEC and let's get this show started.
Schedule 13G issued for Morgan Stanley 6.2% ownership (7.3M) shares of NVAX.
SEC Filing
I am letting the board know I have sold out of my entire Todos position this week. I don't know what the future may hold for Todos, or whether shareholders will ever hear anything more from the insolvency court in Israel, but felt it was time to end this investment journey (or train wreck as some will claim). I followed Todos for several years and despite all the setbacks and changes in political environment that favored big pharma over smaller companies like Todos with better solutions, I kept investing here. I'm now at the point of taking my loss and moving on. I have taken the proceeds from exiting Todos and bought more Novavax, where I already held a position.
I take full responsibility for my decision to invest in Todos. I'm not blaming the CEO or anyone on this board. I truly felt this small company had a chance at success. I didn't agree with every decision Gerald made, but felt he was genuinely trying to make this company a success. He was aggressive in pursuing avenues the government indicated they would likely fund (such as mobile testing and widespread PCR testing). In hindsight, he probably pursued too many different avenues for such a small company. From what I've read about Amarantus, he tended to do that there as well. The point is, I followed his actions and the company's progress and made my own decision to invest. So many people today want to blame others for their decisions when they turn out to be the wrong decision. This was my decision and my ownership of the outcome. You absolutely won't see me posting here for years crying about my losses. I invested a lot because I felt I was in a position to do so without wrecking my finances or my life if it didn't work out. Investing in penny stocks is high risk and I knew the risks involved. My decision to invest — my ownership of the outcome.
I'm not making any recommendation as to whether shareholders should remain invested or exit. For me, this years-long journey needed closure and I wanted to move forward with a greater investment in Novavax. Everyone has reasons for their decisions. Life goes on.
GLTA
The Provista website is still up, so they appear to still be in business. Or the website hosting expense is still being paid.
https://www.provistadx.com
Let me be clear... Todos Medical was a high-risk venture even when things seemed to be going pretty good with increasing revenue at Provista Diagnostics and plans moving forward with Tollovir testing. Now that the company is officially in insolvency proceedings in Israel, the risk is considerably higher.
There are only two possible outcomes from this point, IMO.
1. The court approves the reorganization plan and the company gets another chance, and the stock continues to trade. Whether the company succeeds following reorganization is anyone's guess. But the lawsuit the company has against certain clients is approximately $5M, which is enough to resolve all issues presented to the Israeli courts by the former CEO and 3CL Pharma. But if those companies don't have the cash or the liability insurance to pay the claims if Todos wins the lawsuits, this point is moot.
2. The court does not approve the reorganization plan and the company's assets are liquidated. The stock would stop trading, and shareholders would lose their entire investment.
The stock continues to trade because some feel option 1 is possible. One can purchase 1M shares for only $200 at this point. For some this may be a low-cost lottery ticket for 1-100x return in the coming months. Others may simply be exiting their position to get whatever they can for their remaining shares. MMs may be buying large numbers of shares from those selling to resell to the speculators at 100% profit. I expect the large trading volume will continue until there is news regarding the insolvency proceedings, or the transfer agent halts trading of shares.
There may be another scenario I haven't considered. But in most liquidations, note holders and preferred stock holders are given priority over any funds generated. Common shareholders are low on the recovery totem pole and rarely get anything. I don't believe note holders would be buying the shares we see trading now. They already have a claim in liquidation. I believe it's mainly speculators and MMs generating most of the volume on the buy side from investors who are exiting their positions.
Actually, one other unlikely scenario comes to mind. According to GC's LinkedIn page, he's a managing partner at Fortitude Advisors LLC, which are merger and acquisition experts according to their website. Is it possible something is being pursued there to have Todos Medical acquired by or merged with another company? Perhaps that's what some of the speculators are considering. I am not one of those, but just pointing out a remote possibility. Gerald did say he would find a way to keep Tollovid production going for those who need it.
Never said I owned 78-Mil shares. Read much? I wonder if your "signed" agreement with Gerald actually says what you think it says. That's probably why your attorney won't move forward with your lawsuit... they have read the agreement and understand there's no case against "Gerry", as you called him on the Amarantus conference call. Must have been pretty tight with Gerald to call him Gerry, and having a "signed" agreement that certainly made you feel special among shareholders.
I think we all understand better now the extensive "Gerry" photo collection you have. ♥️ 😍 🥰 ♥️
Classless? I thought it was funny... combining JP's love of pizza with his love of... well, since he's talked about GC's private member so much in private messages, I am sure there's an obsession there.
Classless is blaming everyone else for losing money on an investment. Blaming message board posters for one's loss is the height of classless, yet you remain silent when that is done here, and it's done often here.
Who do you blame? I'm certain it's not the person you see in the mirror. That person has no responsibility, right? I mean, that person had zero to do with investing with Gerald again after losing money in AMBS.
That's classy.
I did buy more. I topped out at 75.8M shares about a month ago. Never ever claimed there was certainty we would be celebrating. Prove otherwise if you believe I did. Stated many times investing in penny stocks like Todos is high risk, high reward. Unfortunately you failed to understand what you were invested in. Greed tends to do that to people. No wonder you're blaming me and others instead of the person in your mirror.
Stock is still trading and someone is still buying shares. Could be shorts trying to cover their trades, or MMs, or possibly even people who believe the insolvency proceedings could result in restructuring the company and possible path forward. Time will tell, but it appears Gerald is no longer part of anything that happens. I can only hope his final claim for Tollovid continuing still holds true, as I've used it for the last two years and want to continue using it.
Let me guess. You're joining in with the imbecile JPetro in bringing a lawsuit against certain posters here. Have at it. That will be about as successful as proving I was ordering pizza for delivery to JP's house. That went nowhere because they couldn't find any evidence against me or anyone else.
I will say this, if that's what is happening. Better be able to prove I was a company shill and I never invested any of my own money in buying 75M shares of Todos stock. I can prove my side. If you can't prove your claims, stand by for a countersuit for my legal bills and damages for wasting my time for everyone involved. And I'm absolutely 100% sure you will lose, because I do have the documentation I will need to defend myself. All courtesy of Fidelity Investments. What do you have, other than baseless claims of a proven liar?
Hop on over to Reddit and read the claims JPetro made on this board, and how I called him out on it, and how he deleted my posts because he was mod of this board and was able to remove all proof to his lies posted here. You're in good company if you're joining any lawsuit he's involved in. Make sure the attorneys involved read it too, as they may have second thoughts about moving forward after reading it.
Good luck with whatever you're planning, snowflake. We all recognize you can't own your decision to invest in Todos. It's someone else's fault, right? We posted our buys and twisted your arm and you were unable to control your greed. It didn't turn out well for any of us. But I own my decision to invest. The only person I blame is ME.
How did you get taken by message board posters? There are many boards where people post outright lies. All that was posted here were opinions. If you believe reposting GC's tweets is posting lies, then that falls on the originator, not those reposting here to satisfy requests from those without X/Twitter accounts. It's up the each individual whether to believe the tweets.
Those posting here in support of Todos and what they were trying to accomplish invested their own money. Many here have constantly reminded the board of how much we as investors were down at all points along the journey. Some even claimed we never really invested, or were paid shills of the company. Idiots are free to post such claims. None have any basis in fact. If you believe that then you join the group of idiots, in fine company with those who still believe the Earth is flat.
If you're trying to say I am responsible for your losses because I was buying shares and posting here, then you have a serious problem and should seek help. And you should definitely stay away from investment message boards. An investor who buys shares because others are buying shares should stick to investing in mutual funds. That's not a good investment strategy. You see this kind of strategy on boards like MONI where buying and selling is driven totally by hype, where the company has never produced anything real or completed any transaction that has been hyped by the company or their agents.. Todos doesn't compare to such a company, as they had real products, real revenue, and real goals.
For the last time, I am not Warp. Your mind has become warped thinking you know who I am. How many different aliases is that you've claimed now? None of them based on reality.
Back to IGNORE.
You misunderstand what I wrote. I suggested using a fake name and email address (made up on the fly) to avoid having your actual name and email address sold to mailing lists, as a way to avoid spam. The website forces you to enter this info in order to view the content. It benefits the website only in this case, not the end user. Since no authentication email is sent in order to listen to the conference, anyone with basic computer security knowledge wouldn't use their own email address in this instance. I also suggested creating a temporary email address for use in these situations, not for routine communication with others and websites where you normally do business.
Only you could twist the intent of the message to mean one has fake credentials and multiple online aliases. Naturally, you are unable to provide any proof. I have been accused by you of being any of up to about half a dozen people. It's all in your mind. Not a shred of proof. NONE
Just like you were going to nail me for ordering pizzas for you. Never did figure out who was doing that, did ya? I guess those Dominos IT guys aren't as good as they claim. Seems there's more to it than capturing an IP address. But I wouldn't expect someone who still uses AOL email to know that.
So you invested because some of us were buying millions of shares, per your earlier post. That's not a good way to invest. Following some here who post on other boards, "BUY BUY BUY!!!" is a recipe for disaster, since every one of those ended up massive losers.
Every individual shareholder is responsible for their own actions. Little boys blame others. Real men see the person responsible in their mirror every day.
Todos Share Update - 2/2/24
No shares issued since update on 12/8/23.
https://www.otcmarkets.com/stock/TOMDF/security
New Phase 3 Trial Data Confirm the Uniquely High Efficacy and Good Safety Profile of the R21/Matrix-M™ Malaria Vaccine in African Children
SERUM INSTITUTE OF INDIA PVT. LTD. — February 1, 2024
https://www.seruminstitute.com/press_release_sii_010224.php
• Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% efficacy in the 5–17-month age group over the first year
• To date 25 million doses manufactured and ready for roll-out by The Serum Institute of India (SII) in the next three to four months
Phase 3 Trial data results of The R21/Matrix-M™ vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax’s Matrix-M™ adjuvant has confirmed high efficacy and supported regulatory approvals and licensure in several African countries. The R21/Matrix-M™ vaccine was designed in 2011 as a potential improvement on the RTS, S/AS01 malaria vaccine designed in the 1980s. A phase II trial in Burkina Faso, reporting in 2021, was the first to show that R21/Matrix-M™ could reach the WHO-specified target of 75% efficacy in African children. Recent WHO endorsement will lead to the initial rollout of R21/Matrix-M™ in the coming months. The new results are published in The Lancet today.
The trial investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% vaccine efficacy over the first year of follow-up across all sites in the 5-17-month-old age group, the age range group which is studied for most malaria vaccines. Efficacy over this period was broadly similar across sites and in different transmission settings. Safety data from the trial have been reassuring with no serious adverse events linked to immunisation. No other vaccine has reported over 55% efficacy in the same age group. A booster dose at a year maintained good efficacy over the following 6-12 months. The vaccine also reduced infection rates in children measured at 12 and 18 months after vaccination suggesting a potentially beneficial effect in reducing malaria transmission.
R21/Matrix-M™ vaccine was well tolerated, with injection site pain and fever as the most frequent adverse events. Number of adverse events of special interest and serious adverse events did not significantly differ between the vaccine groups. There were no treatment-related deaths.
Malaria is the largest cause of death in young African children with over 600,000 deaths globally each year. Two vaccines have recently achieved and completed World Health Organization (WHO) prequalification and initial deployments are starting early this year.
Professor Adrian Hill, chief investigator of the R21/Matrix-M™ phase 3 trial said "The continued high efficacy of this new vaccine in field trials is very encouraging, and consistent with the high efficacy and excellent durability observed in a smaller four-year phase IIb trial. These data support an important role for the unique high-density nanoparticle display, of the conserved repeat region of the malaria parasite circumsporozoite protein, a feature in the design of the R21 vaccine, in providing such high vaccine efficacy and, thereby, an important new tool for malaria control".
Significantly increased immune responses to the R21/Matrix-M™ vaccine and slightly higher vaccine efficacy were observed in 5-17-month-olds compared to 18-36-month-olds malaria vaccines, supporting planned vaccine deployment initially from 5 months of age in young African children.
The vaccine is licensed to the Serum Institute of India (SII), the world’s largest vaccine manufacturer and a long-term partner of the University of Oxford. This is critical because vaccinating those at high risk of malaria will be important in stemming the spread of the disease, as well as protecting the vaccinated. Matrix-M™ adjuvant is manufactured by Novavax AB and provided to Serum Institute of India for formulation into the final vaccine drug product.
Adar Poonawalla, CEO, Serum Institute of India, said: "The Lancet study on R21/Matrix-M™ Phase 3 trials mark a significant advancement in our battle against this global threat. Our collaboration with the University of Oxford has been instrumental in developing the R21/Matrix-M™ malaria vaccine. We are dedicated to making this vaccine available, especially in Africa, where malaria poses a substantial threat to millions of lives, bringing us closer to a malaria-free world".
Professor Alassane Dicko, Principal Investigator in Mali of the R21/Matrix-M™ vaccine, said: "It has been very exciting to generate high efficacy data with the new R21/Matrix-M™ vaccine so quickly. I predict that this vaccine should be very impactful in preventing malaria deaths in African children".
John C Jacobs, CEO of Novavax commented "Approximately 1,300 children die from malaria every day, a staggering statistic for a preventable disease. The R21/Matrix-M™ Phase 3 efficacy data published in The Lancet reinforce the potential of R21/Matrix-M™ vaccine to protect children against this disease. We are proud of the role of Novavax's patented saponin-based Matrix-M™ adjuvant, which has been demonstrated to enhance the immune response, in the outcome of this clinical trial and are eager to see the realized impact of the vaccine when it is rolled out globally".